Table of Content

1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Vaccines Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Infectious Vaccines Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Infectious Vaccines Market by Region
1.4.1 Global Infectious Vaccines Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Infectious Vaccines Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Infectious Vaccines Revenue by Players
2.1.1 Global Infectious Vaccines Revenue by Players (2019-2024)
2.1.2 Global Infectious Vaccines Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Infectious Vaccines Revenue in 2024
2.2 Global Infectious Vaccines Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Infectious Vaccines Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 CSL Limited (Australia)
3.1.1 CSL Limited (Australia) Information
3.1.2 CSL Limited (Australia) Overview
3.1.3 CSL Limited (Australia) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.1.4 CSL Limited (Australia) Related Developments
3.2 Merck and Company (U.S.)
3.2.1 Merck and Company (U.S.) Information
3.2.2 Merck and Company (U.S.) Overview
3.2.3 Merck and Company (U.S.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.2.4 Merck and Company (U.S.) Related Developments
3.3 Emergent Bio Solutions Inc. (U.S.)
3.3.1 Emergent Bio Solutions Inc. (U.S.) Information
3.3.2 Emergent Bio Solutions Inc. (U.S.) Overview
3.3.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.3.4 Emergent Bio Solutions Inc. (U.S.) Related Developments
3.4 Bavarian Nordic (Denmark)
3.4.1 Bavarian Nordic (Denmark) Information
3.4.2 Bavarian Nordic (Denmark) Overview
3.4.3 Bavarian Nordic (Denmark) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.4.4 Bavarian Nordic (Denmark) Related Developments
3.5 Novartis AG (Switzerland)
3.5.1 Novartis AG (Switzerland) Information
3.5.2 Novartis AG (Switzerland) Overview
3.5.3 Novartis AG (Switzerland) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.5.4 Novartis AG (Switzerland) Related Developments
3.6 GlaxoSmithKline plc. (U.K.)
3.6.1 GlaxoSmithKline plc. (U.K.) Information
3.6.2 GlaxoSmithKline plc. (U.K.) Overview
3.6.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.6.4 GlaxoSmithKline plc. (U.K.) Related Developments
3.7 Pfizer Inc. (U.S.)
3.7.1 Pfizer Inc. (U.S.) Information
3.7.2 Pfizer Inc. (U.S.) Overview
3.7.3 Pfizer Inc. (U.S.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.7.4 Pfizer Inc. (U.S.) Related Developments
3.8 Johnson and Johnson (U.S.)
3.8.1 Johnson and Johnson (U.S.) Information
3.8.2 Johnson and Johnson (U.S.) Overview
3.8.3 Johnson and Johnson (U.S.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.8.4 Johnson and Johnson (U.S.) Related Developments
3.9 MedImmune LLC (U.S.)
3.9.1 MedImmune LLC (U.S.) Information
3.9.2 MedImmune LLC (U.S.) Overview
3.9.3 MedImmune LLC (U.S.) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.9.4 MedImmune LLC (U.S.) Related Developments
3.10 Sanofi Pasteur (France)
3.10.1 Sanofi Pasteur (France) Information
3.10.2 Sanofi Pasteur (France) Overview
3.10.3 Sanofi Pasteur (France) Infectious Vaccines Revenue and Gross Margin (2019-2024)
3.10.4 Sanofi Pasteur (France) Related Developments
4 Market Size by Type
4.1 Global Infectious Vaccines Revenue by Type
4.2 Global Infectious Vaccines Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Infectious Vaccines Revenue by Application
5.2 Global Infectious Vaccines Market Size Growth by Application 2019-2024
6 Global Infectious Vaccines Market Insights
6.1 Global Infectious Vaccines Market Revenue 2019-2024
6.2 Global Infectious Vaccines Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Infectious Vaccines Market Size by Country
7.1.1 Americas Infectious Vaccines Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Infectious Vaccines Market Size by Country
8.1.1 Europe Infectious Vaccines Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Infectious Vaccines Market Size by Region
9.1.1 Asia Pacific Infectious Vaccines Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Infectious Vaccines Market Size by Country
10.1.1 Middle East and Africa Infectious Vaccines Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Infectious Vaccines Industry Trends
11.2 Infectious Vaccines Market Drivers
11.3 Infectious Vaccines Market Challenges
11.4 Infectious Vaccines Market Restraints
12 Infectious Vaccines Forecasted Market Size by Type
12.1 Global Infectious Vaccines Forecasted Revenue by Type
12.2 Global Infectious Vaccines Forecasted Market Size Growth by Type 2024-2030
13 Infectious Vaccines Forecasted Market Size by Application
13.1 Global Infectious Vaccines Forecasted Revenue by Application
13.2 Global Infectious Vaccines Forecasted Market Size Growth by Application 2024-2030
14 Global Infectious Vaccines Market Forecasts
14.1 Global Infectious Vaccines Market Revenue Forecasts 2024-2030
14.2 Global Infectious Vaccines Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Infectious Vaccines Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Infectious Vaccines Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Infectious Vaccines Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Infectious Vaccines Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer